Status:
UNKNOWN
Follow-up Strategy for Esophageal Cancer Patients
Lead Sponsor:
Sun Yat-sen University
Conditions:
Esophagus Cancer
Eligibility:
All Genders
18-80 years
Brief Summary
The recurrence risk of patients with esophageal cancer was stratified by integrating different stages and pathological factors. The risk of recurrence was dynamically estimated for each group of patie...
Detailed Description
Patients with histologically proven, esophageal cancer (EC) patients diagnosed between 2008 and 2018 were recruited. Recursive partition analysis was applied to develop recurrence risk stratification ...
Eligibility Criteria
Inclusion
- (1) Patients aged between 18 and 80 years old; (2) Pathological diagnosis as esophageal squamous cell carcinoma or adenocarcinoma; (3) Patients underwent esophagectomy and received R0 resection.
Exclusion
- (1) Patients with secondary primary tumor; (2) Patients who died within 30 days after surgery or died of post-operation complications; (3) Patients missing essential clinical information, such as operation record, pathological diagnosis, and follow-up data; (4) Patients with radiologically or histologically confirmed distant metastasis; (5) Patients previously underwent endoscopic mucosal resection or definitive radiochemotherapy as initial treatment.
Key Trial Info
Start Date :
August 20 2022
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
December 1 2023
Estimated Enrollment :
3000 Patients enrolled
Trial Details
Trial ID
NCT06045715
Start Date
August 20 2022
End Date
December 1 2023
Last Update
September 21 2023
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Jianhua Fu
Guangzhou, Guangdong, China, 510060